Citius Oncology adds Jonathan Peri to its board of directors

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/13/2026

1. WDAY
2. JNJ
3. AAPL
4. AMAT
5. META
6. NVDA
7. NRIX
8. SPY
9. OIG
10. BAC

Go back to Citius Oncology adds Jonathan Peri to its board of directors

Citius Oncology Expands Board with Appointment of Independent Director Jonathan Peri

August 12, 2026 8:00 AM EDT

CRANFORD, N.J., Aug. 12, 2026 /PRNewswire/ -- Citius Oncology, Inc. ("Citius Oncology") (Nasdaq: CTOR), an oncology-focused biopharmaceutical company and majority-owned subsidiary of Citius Pharmaceuticals, Inc. ("Citius Pharma") (Nasdaq: CTXR), today announced that its Board of Directors voted to appoint Jonathan Peri, Ph.D., J.D., as an... More